SPP2

 

Full name: secreted phosphoprotein 2 Alias Symbol: SPP24
Type: protein-coding gene Cytoband: 2q37.1
Entrez ID: 6694 HGNC ID: HGNC:11256 Ensembl Gene: ENSG00000072080 OMIM ID: 602637
Drug and gene relationship at DGIdb

 

Expression of SPP2:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 SPP2 6694 214478_at 0.0309 0.9325
GSE20347 SPP2 6694 214478_at 0.0700 0.3418
GSE23400 SPP2 6694 214478_at -0.1015 0.0287
GSE26886 SPP2 6694 214478_at 0.0212 0.8880
GSE29001 SPP2 6694 214478_at -0.2108 0.0621
GSE38129 SPP2 6694 214478_at -0.0584 0.6821
GSE45670 SPP2 6694 214478_at -0.0027 0.9846
GSE53622 SPP2 6694 76798 0.3720 0.0521
GSE53624 SPP2 6694 76798 0.7286 0.0000
GSE63941 SPP2 6694 214478_at -0.0820 0.6099
GSE77861 SPP2 6694 214478_at -0.1605 0.0595

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by SPP2 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of SPP2:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 SPP2 6694 1 11 18
GSE20123 SPP2 6694 1 11 18
GSE43470 SPP2 6694 1 9 33
GSE46452 SPP2 6694 0 5 54
GSE47630 SPP2 6694 4 5 31
GSE54993 SPP2 6694 3 2 65
GSE54994 SPP2 6694 6 10 37
GSE60625 SPP2 6694 0 3 8
GSE74703 SPP2 6694 1 7 28
GSE74704 SPP2 6694 1 5 14
TCGA SPP2 6694 11 29 56

Total number of gains: 29; Total number of losses: 97; Total Number of normals: 362.  


 

Somatic mutations of SPP2:

 

Generating mutation plots.

 

Highly correlated genes for SPP2:

 

Showing top 20/445 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
SPP2ZKSCAN30.698088303
SPP2FOXN3-AS20.668919303
SPP2ABCC120.665657303
SPP2TRPV50.660239303
SPP2KIR3DL30.652981403
SPP2EPOR0.652859505
SPP2THRB0.651923303
SPP2KIR2DS40.650674303
SPP2ADCYAP1R10.640108404
SPP2NOS10.639737505
SPP2TTPA0.639585303
SPP2CELA10.638414303
SPP2KIR2DL20.633781504
SPP2GPRC5D0.629244303
SPP2TAS2R90.627634404
SPP2ALDOB0.627487404
SPP2BTN1A10.626174504
SPP2DCC0.62556303
SPP2TVP23A0.625198303
SPP2NLRP40.624981303

For details and further investigation, click here